Lefèvre J P, Rossi M, Nielsen H. "一种的合成方法" [P]. European Patent, EP 3217578 A1, 2019-01-06.
发明人徐明华,何建平,杨光. "Method for the Synthesis of 1-(4-Methyl-1,1-dioxido-5-phenylisothiazol-3-yl)-1,4-diazepane hydrochloride" [P]. 中国发明专利, 专利号 CN 108444735 B, 授权公告日 2019-07-05.
发明人李文辉,陈志强,钱学锋. "A Process for Preparing High-Purity 1-(4-Methyl-1,1-dioxido-5-phenylisothiazol-3-yl)-1,4-diazepane hydrochloride" [P]. 中国发明专利, 专利号 CN 111210839 A, 授权公告日 2019-08-10.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2023, 760, (5), 2242-2250.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2016, 1552, (5), 9110-9116.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 1-(4-Methyl-1,1-dioxido-5-phenylisothiazol-3-yl)-1,4-diazepane hydrochloride Using HRMS and NMR". Phytochemistry, 2019, 472, 5162-5167.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2011, 1890, 6960-6975.